Biosynex

ALBIO · PA · Healthcare / Medical Devices

0.82EUR-0.00 (-0.49%)

Price History

Full chart

Market Stats

Previous Close0.824

Open0.82

Day Range0.806 – 0.824

52-Week Range0.455 – 1.57

Volume10.25K

Market Cap16.55M

P/E (TTM)0.00

Forward P/E7.76

EPS-4.03

Dividend Yield0.00%

Beta0.83

50-Day Avg0.9136

200-Day Avg0.8932

About

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products, as well as anti-mosquito bracelets and waterproof, moisturizing, and sensitive skin spray. The company was incorporated in 2005 and is based in Illkirch-Graffenstaden, France.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Larry Abensur
Employees397
Headquarters22 Boulevard SEbastien Brant, Illkirch-Graffenstaden, France, 67400, France
Websitehttps://www.biosynex.com

Leadership

Mr. Larry AbensurChairman & CEO
Dr. Thierry PaperDeputy CEO & Director

Financials

Income Statement

Currency: EUR	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: EUR	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	229.00K	331.00K	485.43K	688.88K	1.01M	1.05M	1.53M	1.82M	4.36M	10.18M	27.14M	30.61M	31.30M	34.23M	153.90M	382.53M	196.59M	92.98M	101.20M	95.20M
Growth (%)	-	+44.54%	+46.66%	+41.91%	+46.19%	+4.31%	+45.90%	+18.88%	+139.27%	+133.55%	+166.55%	+12.79%	+2.25%	+9.37%	+349.59%	+148.57%	-48.61%	-52.70%	+8.84%	-5.93%
Cost of Revenue	294.00K	458.00K	710.78K	510.70K	478.91K	732.90K	437.15K	467.68K	3.39M	7.81M	20.62M	22.08M	22.54M	32.37M	105.80M	199.98M	132.07M	43.85M	43.75M	98.80M
Gross Profit	-	-	-225.35K	178.18K	528.18K	317.61K	1.10M	1.35M	964.74K	2.38M	6.52M	8.53M	8.76M	1.86M	48.10M	182.55M	64.52M	49.13M	-20.00M	-3.60M
Gross Margin	-	-	-46.42%	25.86%	52.45%	30.23%	71.48%	74.33%	22.13%	23.34%	24.03%	27.87%	27.98%	5.43%	31.25%	47.72%	32.82%	52.84%	-19.76%	-3.78%
Operating Expense	-	-	45.45K	429.42K	613.63K	751.43K	1.86M	2.34M	1.65M	2.99M	5.72M	7.61M	8.39M	750.76K	2.36M	41.90M	25.66M	86.54M	1.10M	1.10M
Operating Income	-	-	-270.80K	-251.24K	-85.45K	-433.82K	-764.00K	-990.23K	-689.00K	-610.81K	801.19K	921.86K	371.76K	1.11M	45.73M	140.65M	38.86M	-37.40M	-21.10M	-4.70M
Operating Margin	-	-	-55.79%	-36.47%	-8.48%	-41.30%	-49.85%	-54.35%	-15.80%	-6.00%	2.95%	3.01%	1.19%	3.24%	29.72%	36.77%	19.77%	-40.23%	-20.85%	-4.94%
EBITDA	-	-	-47.84K	-127.01K	56.10K	-157.53K	-445.15K	-677.36K	-1.25M	139.51K	1.29M	1.41M	838.88K	1.64M	51.30M	146.60M	46.73M	-10.18M	-17.83M	8.50M
EBITDA Margin	-	-	-9.86%	-18.44%	5.57%	-15.00%	-29.04%	-37.18%	-28.74%	1.37%	4.76%	4.60%	2.68%	4.80%	33.33%	38.32%	23.77%	-10.95%	-17.61%	8.93%
Net Income	-	-	-162.31K	-224.56K	-28.87K	-326.50K	-722.28K	-1.76M	-1.53M	-364.16K	-120.09K	315.22K	542.89K	1.10M	31.37M	104.00M	15.66M	-36.95M	-43.30M	-58.20M
Net Income Margin	-	-	-33.44%	-32.60%	-2.87%	-31.08%	-47.13%	-96.51%	-35.08%	-3.58%	-0.44%	1.03%	1.73%	3.21%	20.38%	27.19%	7.96%	-39.74%	-42.79%	-61.13%
R&D	-	-	-	-	-	-	-	-	-	140.50K	125.88K	243.00K	-	-	-	-	2.85M	3.92M	-	-
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	1.38%	0.46%	0.79%	-	-	-	-	1.45%	4.21%	-	-
Interest Expense	0	0	40.80K	25.34K	21.97K	16.02K	106.97K	84.31K	65.00K	170.94K	343.39K	286.35K	199.61K	190.00K	224.32K	365.47K	501.00K	2.64M	6.20M	4.44M
Interest Expense % of Total Revenue	0.00%	0.00%	8.41%	3.68%	2.18%	1.53%	6.98%	4.63%	1.49%	1.68%	1.27%	0.94%	0.64%	0.56%	0.15%	0.10%	0.25%	2.84%	6.13%	4.66%

Balance Sheet

Currency: EUR	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: EUR	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	421.00K	375.00K	577.27K	624.41K	1.07M	6.09M	8.85M	7.31M	6.79M	27.95M	39.51M	40.51M	39.46M	47.34M	126.07M	268.94M	259.98M	241.73M	194.69M	136.24M
Total Liabilities	424.00K	496.00K	731.01K	965.95K	942.86K	924.34K	3.67M	3.35M	3.35M	6.82M	15.15M	11.60M	10.20M	16.97M	59.78M	101.14M	93.21M	117.41M	114.19M	101.29M
Total Equity	-	-	-156.98K	-341.55K	124.59K	5.16M	5.18M	3.96M	3.45M	21.13M	24.36M	28.91M	29.26M	30.38M	66.29M	167.81M	162.40M	124.48M	80.58M	32.44M
Cash	7.00K	-	1.39K	4.89K	70.83K	171.01K	120.55K	177.21K	1.09M	1.06M	599.22K	2.02M	1.85M	1.85M	36.84M	132.03M	87.17M	20.17M	4.69M	8.46M
Total Debt	-	-	544.85K	491.25K	409.40K	386.75K	2.62M	2.55M	1.69M	4.07M	6.89M	5.90M	5.18M	11.44M	15.77M	35.31M	52.07M	65.60M	62.46M	61.65M
Net Debt	-	-	543.47K	486.35K	338.57K	215.74K	2.50M	2.37M	601.70K	3.02M	6.29M	3.88M	3.33M	8.12M	-21.07M	-96.72M	-35.10M	45.43M	57.77M	53.19M

Cash Flow

Currency: EUR	2007-12-31	2008-12-31	2009-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	-184.44K	72.40K	-	-	461.66K	489.91K	484.82K	467.12K	1.10M	31.64M	109.83M	4.95M	-9.65M	-10.12M	-5.89M
Investing Cash Flow	-	-104.35K	-162.94K	-	-	-	-	-7.93M	-7.93M	-7.93M	-7.93M	-28.96M	-39.08M	-54.81M	-4.60M	3.04M
Financing Cash Flow	114.00K	368.34K	133.03K	-	-	-	-	10.62M	10.62M	10.62M	10.62M	14.40M	-10.81M	5.17M	-801.00K	6.91M
Capital Expenditure	26.00K	23.31K	46.92K	0	0	0	0	9.12M	9.12M	9.12M	9.12M	19.02M	30.08M	39.54M	4.84M	2.69M
Free Cash Flow	-	-207.75K	25.48K	-	-	461.66K	489.91K	484.82K	467.12K	1.10M	22.52M	90.82M	-25.13M	-49.20M	-14.96M	-8.57M
Dividends Paid	-	-	-	-	-	-	-	-	1.94M	1.94M	1.94M	22.31M	20.44M	-	-	-
FCF to OCF	-	112.64%	35.19%	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	71.18%	82.69%	-508.24%	509.61%	147.82%	145.59%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	414.37%	175.33%	8.60%	24.57%	-81.34%	-	-	-

Earnings

Report Date	Jun 30, 2016	Nov 3, 2016	Jul 24, 2017	Nov 1, 2017	May 11, 2018	Oct 30, 2018	Jun 10, 2019	Nov 26, 2019	May 4, 2020	Dec 1, 2020	Apr 29, 2021	Apr 22, 2022	Oct 20, 2022	Nov 3, 2024	Apr 30, 2025	Oct 30, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
EPS Actual	-0.13	0.00	-0.01	0.12	-0.07	0.02	0.04	0.07	0.06	0.65	2.40	2.76	2.97	-1.95	-2.08	-2.59
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	-	-	-

Key Statistics & Ratios

Market Cap16.55M

Enterprise Value69.93M

Trailing P/E0.00

Forward P/E7.76

PEG Ratio0.00

Price / Sales0.17

Price / Book0.48

EPS-4.03

Book Value2.00

Revenue (TTM)95.19M

Gross Profit (TTM)52.36M

EBITDA-13.64M

Profit Margin-61.16%

Operating Margin17.37%

Return on Equity-95.94%

Return on Assets-9.84%

Shares Outstanding18.43M

Shares Float7.63M

Beta0.83

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20221×

1.65May 16, 2022

20211×

0.17May 26, 2021

Stock Splits

Jan 24, 2025867:716
Jul 5, 2017697:694
Dec 2, 20161022:993
Oct 22, 2015527:515
Dec 4, 20141715:1647
May 23, 2011189:185